Cargando…
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
BACKGROUND: The CD4 cell count at which combination antiretroviral therapy should be started is a central, unresolved issue in the care of HIV-1-infected patients. In the absence of randomised trials, we examined this question in prospective cohort studies. METHODS: We analysed data from 18 cohort s...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670965/ https://www.ncbi.nlm.nih.gov/pubmed/19361855 http://dx.doi.org/10.1016/S0140-6736(09)60612-7 |
Ejemplares similares
-
SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy
por: Cheung, Peter K., et al.
Publicado: (2023) -
Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV
por: Chambers, Catharine, et al.
Publicado: (2022) -
COVID-19 vaccine immunogenicity in people with HIV
por: Costiniuk, Cecilia T., et al.
Publicado: (2023) -
Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options
por: Botha, Jean, et al.
Publicado: (2018) -
Consequences of a changing US strategy in the global HIV investment landscape
por: McGillen, Jessica B., et al.
Publicado: (2017)